The TREOCAPA study – Paracetamol in Premature Babies – to assess the effectiveness of paracetamol in premature babies with a patent ductus arteriosus – successfully completed the recruitment phase, with 100% of the target achieved: 804 babies in 14 countries! Portugal was the 5th country with the highest contribution to recruitment, with the inclusion of...Continue Reading
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777389. The Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA
